Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
PR

PRGO

Market Closed

Perrigo Company plc

NYSEHealthcareDrug Manufacturers - Specialty & Generic
IE
8.32K employees
CEO: Patrick Lockwood-Taylor
Founded: 1991
$11.02
+$0.00(+NaN%)
Market Cap
1.52B
Beta
0.52
52W Range
N/A
Dividend Yield
10.53%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Perrigo's current price at $9.95 contrasts sharply with a high-confidence fair value of $330.05, indicating significant undervaluation potential paired with high volatility (CV 146.71%). Despite strong liquidity, poor profitability and efficiency scores highlight operational challenges and heightened risk. Monte Carlo analysis shows zero downside scenarios below current price, suggesting limited near-term price risk but broad outcome uncertainty.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PRGO

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PRGO in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms